Pulsed Electromagnetic Field Therapy (PEMF)
Pulsed Electromagnetic Field (PEMF) therapy is a safe, and non-invasive way to reduce pain and inflammation. It can be used to supplement and enhance currently existing healthcare modalities. The PEMF apparatus includes various devices including full body mats, localized pad applicators, and pinpointed probe or “spot” applicators.
This study says:
PEMFs inhibit angiogenesis in tumor tissues, suppressing tumor vascularization and reducing tumor growth, as shown by in vivo studies. The specific claim, supported by the described in vivo studies, is that all treated groups showed slower tumor growth rate if compared with untreated control group, confirming that PEMF therapy can modulate the physiology and electrochemistry of cancer cells and influence cell membrane systems and mitosis…PEMFs have also an immunomodulatory effect, as supported by in vivo evidence showing an increase in tumor necrosis factor alpha levels that induce an anti-tumoral response….
This study says: Based on our data it appears that PEMF-based anticancer strategies may represent a new therapeutic approach to treat breast cancer without affecting normal tissues in a manner that is non-invasive and can be potentially combined with existing anti-cancer treatments.
This study says:
In conclusion, only two clinical studies have used PEMF therapy for cancer treatment. These studies show that PEMF therapy is safe and promising compared to other available cancer therapies. In the future, PEMFs could be used not only as primary therapy but also in combination with other common antineoplastic therapies.
This study includes the following: Patients with advanced hepatocellular carcinoma (HCC) have severely impaired liver function and therefore cannot tolerate standard chemotherapy or intrahepatic treatments. Therefore, recently Phase I/II clinical study involving PEMF treatment of forty-one advanced HCC patients has been carried out by Costa et al.. In this study, the patients were treated with low levels of pulsed electromagnetic fields (100 Hz – 21 kHz) for 60 min (three times/day). Majority of the patients exhibited complete disappearance (5 patients) or immediate reduction in pain (2 patients) due to this treatment and no toxicities were observed. This study clearly showed stable disease (39%) for more than 12 weeks and therefore potentially provides safe and well tolerable treatment for HCC.
Published Clinical Trials / Studies / Reviews
Where can I get this treatment and more information??